Prudential PLC Gilead Sciences, Inc. Transaction History

Prudential PLC

$19.6 Billion
Q3 2024

A detailed history of Prudential PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Prudential PLC holds 281,004 shares of GILD stock, worth $26.1 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

281,004

Previous 319,162 11.96%

Holding current value

$26.1 Million

Previous $21.9 Million 7.56%

% of portfolio

0.12%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $2.54 Million - $3.2 Million	-38,158 Reduced 11.96%	281,004 $23.6 Million
Q2 2024 Aug 06, 2024	SELL	$63.15 - $72.88 $2.03 Million - $2.35 Million	-32,218 Reduced 9.17%	319,162 $21.9 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $10.9 Million - $13.2 Million	151,697 Added 75.97%	351,380 $25.7 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $1.45 Million - $1.65 Million	-19,844 Reduced 9.04%	199,683 $16.2 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $1.08 Million - $1.18 Million	14,657 Added 7.15%	219,527 $16.5 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $589,381 - $672,271	-7,754 Reduced 3.65%	204,870 $15.8 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $1.03 Million - $1.18 Million	-13,385 Reduced 5.92%	212,624 $17.6 Million
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $2.68 Million - $3.85 Million	43,068 Added 23.54%	226,009 $19.4 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $21,196 - $24,211	-356 Reduced 0.19%	182,941 $11.3 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $809,523 - $911,765	-14,025 Reduced 7.11%	183,297 $11.3 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $8.2 Million - $10.3 Million	141,640 Added 254.37%	197,322 $11.7 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $1.92 Million - $2.17 Million	29,534 Added 112.95%	55,682 $4.04 Million
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $7.2 Million - $7.77 Million	-106,353 Reduced 80.27%	26,148 $1.83 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $8.39 Million - $9.17 Million	-132,187 Reduced 49.94%	132,501 $9.12 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $15.9 Million - $18.1 Million	264,688 New	264,688 $17.1 Million
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $116 Million - $145 Million	-1,863,101 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $31.2 Million - $36.2 Million	430,760 Added 30.07%	1,863,101 $143 Million
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $89.2 Million - $114 Million	1,423,870 Added 16808.76%	1,432,341 $107 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $166 Million - $182 Million	-2,689,085 Reduced 99.69%	8,471 $550,000
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $8.05 Million - $8.89 Million	-128,775 Reduced 4.56%	2,697,556 $171 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $18.3 Million - $20.5 Million	-296,067 Reduced 9.48%	2,826,331 $191 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $2.04 Million - $2.28 Million	32,583 Added 1.05%	3,122,398 $203 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $12.1 Million - $15.8 Million	-199,735 Reduced 6.07%	3,089,815 $193 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $39.8 Million - $44 Million	-558,140 Reduced 14.51%	3,289,550 $254 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $22 Million - $25.7 Million	339,324 Added 9.67%	3,847,690 $273 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $7.51 Million - $9.15 Million	103,039 Added 3.03%	3,508,366 $264 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $17.6 Million - $20.7 Million	247,331 Added 7.83%	3,405,327 $244 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $26.5 Million - $31.4 Million	-367,171 Reduced 10.42%	3,157,996 $256 Million
Q2 2017 Aug 14, 2017	BUY	N/A	3,525,167	3,525,167 $250 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

993M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account